Advanced search
Publication Cover
The Physician and Sportsmedicine Volume 38, 2010 - Issue 2
Submit an article Journal homepage
12
Views
0
CrossRef citations to date
0
Altmetric
Practice Pearl

Ibandronate and Nonvertebral Fracture Efficacy: Results of a Recent Pooled Analysis

John A. Sunyecz MenopauseRx, Inc., Uniontown, PACorrespondence[email protected]
, MD, FACOG
Pages 183-185 | Published online: 13 Mar 2015

References

  • . Emkey R, Koltun W, Beusterien K, . Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO). Curr Med Res Opin. 2005;21(12):1895–903
  • . Rossini M, Viapiana O, Gatti D, Adami S. Once-monthly oral ibandronate in postmenopausal osteoporosis: translation and updated review. Clin Ther. 2009;31(7):1497–1510
  • . Cranney A, Wells GA, Yetisir E, . Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data. Osteoporos Int. 2009;20(2):291–297
  • . Harris ST, Blumentals WA, Miller PD. Ibandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studies. Curr Med Res Opin. 2008;24(1):237–245
  • . Delmas PD, Recker RR, Chesnut CH III, . Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. Osteoporos Int. 2004;15(10):792–798
  • . Chesnut CH III, Skag A, Christiansen C, ; Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE). Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteorporosis. J Bone Miner Res. 2004;8:1241–1249
  • . Miller PD, McClung MR, Macovei L, . Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study. J Bone Miner Res. 2005;20(8):1315–1322
  • . Delmas PD, Adami S, Strugala C, . Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. Arthritis Rheum. 2006;54(6):1838–1846
  • . Epstein S, Delmas PD, Emkey R, . Oral ibandronate in the management of postmenopausal osteoporosis: review of upper gastrointestinal safety. Maturitas. 2006;20;54(1):1–10
  • . Strampel W, Emkey R, Civitelli R. Safety considerations with bisphosphonates for the treatment of osteoporosis. Drug Saf. 2007;30(9):755–763

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.